View in EDS

Safety and Glycemic Outcomes During the MiniMedTM Advanced Hybrid Closed-Loop System Pivotal Trial in Children and Adolescents with Type 1 Diabetes.

Saved in:
Bibliographic Details
Title: Safety and Glycemic Outcomes During the MiniMedTM Advanced Hybrid Closed-Loop System Pivotal Trial in Children and Adolescents with Type 1 Diabetes.
Authors: Pihoker C; Department of Pediatrics, University of Washington, Seattle, Washington, USA., Shulman DI; University of South Florida, Pediatric Diabetes and Endocrinology, Tampa, Florida, USA., Forlenza GP; Department of Pediatrics, Barbara Davis Center of Childhood Diabetes, Aurora, Colorado, USA., Kaiserman KB; SoCal Diabetes, Torrance, California, USA., Sherr JL; Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, USA., Thrasher JR; Arkansas Diabetes and Endocrinology Center, Little Rock, Arkansas, USA., Buckingham BA; Stanford University School of Medicine, Pediatric Diabetes and Endocrinology, Stanford, California, USA., Kipnes MS; Diabetes and Glandular Disease Clinic, San Antonio, Texas, USA., Bode BW; Atlanta Diabetes Associates, Atlanta, Georgia, USA., Carlson AL; International Diabetes Center, HealthPartners Institute, Minneapolis, Minnesota, USA., Lee SW; Department of Endocrinology, Loma Linda University, Loma Linda, California, USA., Latif K; AM Diabetes and Endocrinology Center, Bartlett, Tennessee, USA., Liljenquist DR; Rocky Mountain Diabetes and Osteoporosis Center, Idaho Falls, Idaho, USA., Slover RH; Department of Pediatrics, Barbara Davis Center of Childhood Diabetes, Aurora, Colorado, USA., Dai Z; Medtronic, Northridge, California, USA., Niu F; Medtronic, Northridge, California, USA., Shin J; Medtronic, Northridge, California, USA., Jonkers RAM; Medtronic, Northridge, California, USA., Roy A; Medtronic, Northridge, California, USA., Grosman B; Medtronic, Northridge, California, USA., Vella M; Medtronic, Northridge, California, USA., Cordero TL; Medtronic, Northridge, California, USA., McVean J; Medtronic, Northridge, California, USA., Rhinehart AS; Medtronic, Northridge, California, USA., Vigersky RA; Medtronic, Northridge, California, USA.
Corporate Authors: MiniMed AHCL Study Group
Source: Diabetes technology & therapeutics [Diabetes Technol Ther] 2023 Nov; Vol. 25 (11), pp. 755-764. Date of Electronic Publication: 2023 Oct 25.
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100889084 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-8593 (Electronic) Linking ISSN: 15209156 NLM ISO Abbreviation: Diabetes Technol Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37782145
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Safety and Glycemic Outcomes During the MiniMed<superscript>TM</superscript> Advanced Hybrid Closed-Loop System Pivotal Trial in Children and Adolescents with Type 1 Diabetes.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Pihoker+C%22">Pihoker C</searchLink>; Department of Pediatrics, University of Washington, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Shulman+DI%22">Shulman DI</searchLink>; University of South Florida, Pediatric Diabetes and Endocrinology, Tampa, Florida, USA.<br /><searchLink fieldCode="AU" term="%22Forlenza+GP%22">Forlenza GP</searchLink>; Department of Pediatrics, Barbara Davis Center of Childhood Diabetes, Aurora, Colorado, USA.<br /><searchLink fieldCode="AU" term="%22Kaiserman+KB%22">Kaiserman KB</searchLink>; SoCal Diabetes, Torrance, California, USA.<br /><searchLink fieldCode="AU" term="%22Sherr+JL%22">Sherr JL</searchLink>; Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut, USA.<br /><searchLink fieldCode="AU" term="%22Thrasher+JR%22">Thrasher JR</searchLink>; Arkansas Diabetes and Endocrinology Center, Little Rock, Arkansas, USA.<br /><searchLink fieldCode="AU" term="%22Buckingham+BA%22">Buckingham BA</searchLink>; Stanford University School of Medicine, Pediatric Diabetes and Endocrinology, Stanford, California, USA.<br /><searchLink fieldCode="AU" term="%22Kipnes+MS%22">Kipnes MS</searchLink>; Diabetes and Glandular Disease Clinic, San Antonio, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Bode+BW%22">Bode BW</searchLink>; Atlanta Diabetes Associates, Atlanta, Georgia, USA.<br /><searchLink fieldCode="AU" term="%22Carlson+AL%22">Carlson AL</searchLink>; International Diabetes Center, HealthPartners Institute, Minneapolis, Minnesota, USA.<br /><searchLink fieldCode="AU" term="%22Lee+SW%22">Lee SW</searchLink>; Department of Endocrinology, Loma Linda University, Loma Linda, California, USA.<br /><searchLink fieldCode="AU" term="%22Latif+K%22">Latif K</searchLink>; AM Diabetes and Endocrinology Center, Bartlett, Tennessee, USA.<br /><searchLink fieldCode="AU" term="%22Liljenquist+DR%22">Liljenquist DR</searchLink>; Rocky Mountain Diabetes and Osteoporosis Center, Idaho Falls, Idaho, USA.<br /><searchLink fieldCode="AU" term="%22Slover+RH%22">Slover RH</searchLink>; Department of Pediatrics, Barbara Davis Center of Childhood Diabetes, Aurora, Colorado, USA.<br /><searchLink fieldCode="AU" term="%22Dai+Z%22">Dai Z</searchLink>; Medtronic, Northridge, California, USA.<br /><searchLink fieldCode="AU" term="%22Niu+F%22">Niu F</searchLink>; Medtronic, Northridge, California, USA.<br /><searchLink fieldCode="AU" term="%22Shin+J%22">Shin J</searchLink>; Medtronic, Northridge, California, USA.<br /><searchLink fieldCode="AU" term="%22Jonkers+RAM%22">Jonkers RAM</searchLink>; Medtronic, Northridge, California, USA.<br /><searchLink fieldCode="AU" term="%22Roy+A%22">Roy A</searchLink>; Medtronic, Northridge, California, USA.<br /><searchLink fieldCode="AU" term="%22Grosman+B%22">Grosman B</searchLink>; Medtronic, Northridge, California, USA.<br /><searchLink fieldCode="AU" term="%22Vella+M%22">Vella M</searchLink>; Medtronic, Northridge, California, USA.<br /><searchLink fieldCode="AU" term="%22Cordero+TL%22">Cordero TL</searchLink>; Medtronic, Northridge, California, USA.<br /><searchLink fieldCode="AU" term="%22McVean+J%22">McVean J</searchLink>; Medtronic, Northridge, California, USA.<br /><searchLink fieldCode="AU" term="%22Rhinehart+AS%22">Rhinehart AS</searchLink>; Medtronic, Northridge, California, USA.<br /><searchLink fieldCode="AU" term="%22Vigersky+RA%22">Vigersky RA</searchLink>; Medtronic, Northridge, California, USA.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22MiniMed+AHCL+Study+Group%22">MiniMed AHCL Study Group</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100889084%22">Diabetes technology & therapeutics</searchLink> [Diabetes Technol Ther] 2023 Nov; Vol. 25 (11), pp. 755-764. <i>Date of Electronic Publication: </i>2023 Oct 25.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Mary+Ann+Liebert%2C+Inc%22">Mary Ann Liebert, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>100889084 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1557-8593 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215209156%22">15209156 </searchLink><i>NLM ISO Abbreviation: </i>Diabetes Technol Ther <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37782145
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1089/dia.2023.0255
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 755
    Titles:
      – TitleFull: Safety and Glycemic Outcomes During the MiniMedTM Advanced Hybrid Closed-Loop System Pivotal Trial in Children and Adolescents with Type 1 Diabetes.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Pihoker C
      – PersonEntity:
          Name:
            NameFull: Shulman DI
      – PersonEntity:
          Name:
            NameFull: Forlenza GP
      – PersonEntity:
          Name:
            NameFull: Kaiserman KB
      – PersonEntity:
          Name:
            NameFull: Sherr JL
      – PersonEntity:
          Name:
            NameFull: Thrasher JR
      – PersonEntity:
          Name:
            NameFull: Buckingham BA
      – PersonEntity:
          Name:
            NameFull: Kipnes MS
      – PersonEntity:
          Name:
            NameFull: Bode BW
      – PersonEntity:
          Name:
            NameFull: Carlson AL
      – PersonEntity:
          Name:
            NameFull: Lee SW
      – PersonEntity:
          Name:
            NameFull: Latif K
      – PersonEntity:
          Name:
            NameFull: Liljenquist DR
      – PersonEntity:
          Name:
            NameFull: Slover RH
      – PersonEntity:
          Name:
            NameFull: Dai Z
      – PersonEntity:
          Name:
            NameFull: Niu F
      – PersonEntity:
          Name:
            NameFull: Shin J
      – PersonEntity:
          Name:
            NameFull: Jonkers RAM
      – PersonEntity:
          Name:
            NameFull: Roy A
      – PersonEntity:
          Name:
            NameFull: Grosman B
      – PersonEntity:
          Name:
            NameFull: Vella M
      – PersonEntity:
          Name:
            NameFull: Cordero TL
      – PersonEntity:
          Name:
            NameFull: McVean J
      – PersonEntity:
          Name:
            NameFull: Rhinehart AS
      – PersonEntity:
          Name:
            NameFull: Vigersky RA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: 2023 Nov
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1557-8593
          Numbering:
            – Type: volume
              Value: 25
            – Type: issue
              Value: 11
          Titles:
            – TitleFull: Diabetes technology & therapeutics
              Type: main
ResultId 1